Clinical trial NCT02613533: Water Drinking Test in Patients With Occludable Angle
Official title: What is the Effect of the "Water Drinking Test" on Patients With Narrow Angles on the Day of Their Scheduled Laser Iridotomy?
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Glaucoma
Lead sponsor: Wills Eye
Sponsor class: OTHER
First posted: 2015-11-24
Enrollment: 20
Sex: ALL
Minimum age (years): 21
Maximum age (years): 90
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: The water drinking test (WDT), is a predictive test that has been used to detect primary open angle glaucoma and recently has been demonstrated as a predictor of the diurnal tension curve. Clinically accurate provocative tests for asymptomatic eyes with shallow anterior chambers and narrow angles are highly desirable to detect patients prone to angle closure glaucoma. The aim of this pilot study is to evaluate the possible role of water drinking test in patients with narrow angles who are scheduled for prophylactic laser iridotomy.

Detailed description: This prospective case series will investigate the effects of the WDT on subjects with narrow anterior chamber angles on the day of their scheduled laser iridotomy. The angle configuration and IOP will be monitored following the WDT. Twenty patients with occludable angles will be enrolled in this study. After measuring the baseline IOP, weight and height, the patients will be asked to drink 10ml/kg water over 15 minutes (equal to approximately 0.33 ounces of water for every 2.2 pounds of weight or 2 ½ cups for a 150 lb. individual) and their IOP will be checked every 15 minutes up to one hour after drinking the water. This will be repeated after performing a laser iridotomy. The data obtained, mainly IOP and gonioscopic findings, will be analyzed using statistical tests and compared to historical controls of the WDT without narrow angles, and laser iridotomy subjects without the WDT.

Eligibility criteria: Inclusion Criteria:

* narrow angle judged to be at risk of attack by the treating physician, with one or more quadrants not open to the sclera spur on gonioscopy
* age between 21 and 90 years
* ability to give informed consent.

Exclusion Criteria:

* baseline IOP higher than 21 mm Hg with or without medication
* other causes of glaucoma, such as pseudoexfoliative and pigmentary glaucomas
* previous treatment with argon laser or selective laser trabeculoplasty
* previous refractive sugary; (5) pregnant women; (6) congestive heart failure
* renal failure or urinary retention issues; (8) corneal abnormalities preventing reliable IOP measurement
* non-glaucomatous optic neuropathy
* prior refractive surgery or other issues preventing accurate Goldmann applanation tonometry
* prior intraocular surgery

Primary outcomes:
measure: Intra-ocular pressure measurement
timeFrame: every 15 minutes before and after surgery for upto an hour
Secondary outcomes:
Other outcomes:
Locations:
city: Philadelphia
country: United States
facility: Wills Eye Institute
state: Pennsylvania
Study officials:
affiliation: Wills Eye
name: Jonathan Myers, MD
role: PRINCIPAL_INVESTIGATOR
References: